USD
+$0.00
(+0.00%
)At Close (As of Dec 12, 2025)
$15.89M
Market Cap
-
P/E Ratio
-1.8
EPS
$1.97
52 Week High
$0.48
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$4.2M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $1.9M |
| Capital Expenditures | $10M |
| Change In Receivables | - |
| Change In Inventory | -$1.7M |
| Profit Loss | - |
| Cashflow From Investment | -$23M |
| Cashflow From Financing | $29M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | $0 |
| Dividend Payout Common Stock | $0 |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$32M |
| Field | Value |
|---|---|
| Ex Dividend Date | 2015-06-05 |
| Declaration Date | None |
| Record Date | None |
| Payment Date | None |
| Amount | 0.22 |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Trinity Biotech plc is a leading innovator in the medical diagnostics sector, specializing in the development, manufacture, and marketing of advanced diagnostic products for both clinical laboratories and point-of-care settings. Based in Bray, Ireland, the company boasts a robust global presence spanning the United States, Europe, Africa, and Asia, strategically addressing the growing demand for quick and dependable diagnostic solutions. Committed to enhancing patient outcomes, Trinity Biotech is actively expanding its product portfolio through innovative initiatives, positioning itself as a vital player in the evolving landscape of healthcare diagnostics.